‹ All stocks
electroCore
ECOR · NASDAQ · Healthcare
$10.32
▼ $0.50 (-4.62%)
Day range
$10.00 – $11.08
Year range
$4.41 – $12.70
Open
$11.00
Previous close
$10.82
Market cap
$93.04M
Volume (24h)
$97.3K
Volume (52w)
$1.00M
Performance
7D
▼ -6.44%
1M
▲ 13.66%
3M
▲ 30.47%
6M
▲ 66.18%
1Y
▲ 105.99%
YTD
▲ 126.81%
3Y
▲ 84.62%
5Y
▼ -32.55%
All-time
▼ -96.53%
Key statistics
P/E ratio
-6.22
EPS (TTM)
$-1.66
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
9.0M
About electroCore
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1156.42 | 0.49% |
JNJ Johnson & Johnson |
$254.52 | -0.58% |
ABBV AbbVie |
$262.04 | 0.29% |
MRK Merck & Co. |
$139.70 | -2.76% |
UNH UnitedHealth Group Incorp… |
$371.61 | -0.19% |